12 Segmentation of Symptomatic Exudate-Associated …
363
References
1. R.D. Jager, W.F. Mieler, J.W. Miller, Age-related macular degeneration. N. Engl. J. Med. 358,
2606–2617 (2008)
2. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung, R.Y. Kim,
Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355,
1419–1431 (2006)
3. N. Ferrara, K.J. Hilan, H. Gerber, W. Novetny, Discovery and development of bevacizumab,
an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discovery 3, 391–400 (2004)
4. P.V. Algvere, B. Steén, S. Seregard, A. Kvanta, A prospective study on intravitrealbevacizumab
(Avastin®) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol. 86, 482–489 (2008)
5. C. Cukras, Y.D. Wang, C.B. Meyerle, F. Forooghian, E.Y. Chew, W.T. Wong, Optical coherence
tomography-based decision making in exudative age-related macular degeneration: comparison
of time- versus spectral-domain devices. Eye 24, 775–783 (2010)
6. G.A. Lalwani, P.J. Rosenfeld, A.E. Fung, S.R. Dubovy, S. Michels, W. Feuer, J.L. Davis,
H.W. Flynn Jr., M. Esquiabro, A variable-dosing regimen with intravitrealranibizumab for
neovascular age-related macular degeneration: year 2 of the PrONTO study. Am. J. Ophthalmol.
148, 43–58 (2009)
7. F. Coscas, G. Coscas, E. Souied, S. Tick, G. Soubrane, Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am. J.
Ophthalmol. 144, 592–599 (2007)
8. A.H. Kashani, P.A. Keane, L. Dustin, A.C. Walsh, S.R. Sadda, Quantitative subanalysis of
cystoid spaces and outer nuclear layer using optical coherence tomography in age-related
macular degeneration. Invest. Ophthalmol. Vis. Sci. 50, 3366–3373 (2009)
9. A.E. Fung, G.A. Lalwani, P.J. Rosenfeld, S.R. Dubovy, S. Michels, W.J. Feuer, C.A. Puliafito,
J.L. Davis, H.W. Flynn Jr., M. Esquiabro, An optical coherence tomography-guided, variable
dosing regimen with intravitrealranibizumab (Lucentis) for neovascular age-related macular
degeneration. Am. J. Ophthalmol. 143, 566–583 (2007)
10. H. Dadgostar, A.A. Ventura, J.Y. Chung, S. Sharma, P.K. Kaiser, Evaluation of injection frequency and visual acuity outcomes for ranibizumabmonotherapy in exudative age-related macular degeneration. Am. J. Ophthalmol. 116, 1740–1747 (2009)
11. A. Delong, Y. Boykov. Globally optimal segmentation of multi-region objects, in IEEE International Conference on Computer Vision (ICCV) (2009)
12. K. Li, X. Wu, D.Z. Chen, M. Sonka, Efficient optimal surface detection: theory, implementation and experimental validation. in Proceedings of SPIE International Symposium Medical
Imaging: Image Processing, vol. 5370 (May 2004), pp. 620–627
13. Y. Boykov, G. Funka-Lea, Graph cuts and efficient N-D image segmentation. Int. J. Comput.
Vis. (IJCV) 70, 109–131 (2006)
14. M. Niemeijer, K. Lee, X. Chen, L. Zhang, M. Sonka, M.D Abràmoff, Automated estimation of
fluid volume in 3D OCT scans of patients with CNV due to AMD, in ARVO Annual Meeting
(2012)
15. Y. Boykov, V. Kolmogorov, An experimental comparison of min-cut/max-flow algorithms for
energy minimization in vision. IEEE Trans. Pattern Anal. Mach. Intell. 26, 1124–1137 (2004)
16. X. Chen, M. Niemeijer, L. Zhang, K. Lee, M.D. Abràmoff, M. Sonka, 3D segmentation of fluidassociated abnormalities in retinal OCT: probability constrained graph-search–graph-cut. IEEE
Trans. Med. Imaging 31(8), 1521–1531 (2012)
17. Y. Boykov, M.P. Jolly, Interactive graph cuts for optimal boundary and region segmentation of
objects in ND images, in IEEE International Conference on Computer Vision (ICCV), vol. I
(2001), pp. 105–112
18. V. Kolmogorov, R. Zabih, What energy function can be minimized via graph cuts? IEEE Trans.
Pattern Anal. Mach. Intell. 26, 147–159 (2004)
19. O. Veksler, Star shape prior for graph-cut image segmentation, in 10th European Conference
on Computer Vision (ECCV), vol. 5304 (2008), pp. 454–467
363
References
1. R.D. Jager, W.F. Mieler, J.W. Miller, Age-related macular degeneration. N. Engl. J. Med. 358,
2606–2617 (2008)
2. P.J. Rosenfeld, D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung, R.Y. Kim,
Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355,
1419–1431 (2006)
3. N. Ferrara, K.J. Hilan, H. Gerber, W. Novetny, Discovery and development of bevacizumab,
an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discovery 3, 391–400 (2004)
4. P.V. Algvere, B. Steén, S. Seregard, A. Kvanta, A prospective study on intravitrealbevacizumab
(Avastin®) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol. 86, 482–489 (2008)
5. C. Cukras, Y.D. Wang, C.B. Meyerle, F. Forooghian, E.Y. Chew, W.T. Wong, Optical coherence
tomography-based decision making in exudative age-related macular degeneration: comparison
of time- versus spectral-domain devices. Eye 24, 775–783 (2010)
6. G.A. Lalwani, P.J. Rosenfeld, A.E. Fung, S.R. Dubovy, S. Michels, W. Feuer, J.L. Davis,
H.W. Flynn Jr., M. Esquiabro, A variable-dosing regimen with intravitrealranibizumab for
neovascular age-related macular degeneration: year 2 of the PrONTO study. Am. J. Ophthalmol.
148, 43–58 (2009)
7. F. Coscas, G. Coscas, E. Souied, S. Tick, G. Soubrane, Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am. J.
Ophthalmol. 144, 592–599 (2007)
8. A.H. Kashani, P.A. Keane, L. Dustin, A.C. Walsh, S.R. Sadda, Quantitative subanalysis of
cystoid spaces and outer nuclear layer using optical coherence tomography in age-related
macular degeneration. Invest. Ophthalmol. Vis. Sci. 50, 3366–3373 (2009)
9. A.E. Fung, G.A. Lalwani, P.J. Rosenfeld, S.R. Dubovy, S. Michels, W.J. Feuer, C.A. Puliafito,
J.L. Davis, H.W. Flynn Jr., M. Esquiabro, An optical coherence tomography-guided, variable
dosing regimen with intravitrealranibizumab (Lucentis) for neovascular age-related macular
degeneration. Am. J. Ophthalmol. 143, 566–583 (2007)
10. H. Dadgostar, A.A. Ventura, J.Y. Chung, S. Sharma, P.K. Kaiser, Evaluation of injection frequency and visual acuity outcomes for ranibizumabmonotherapy in exudative age-related macular degeneration. Am. J. Ophthalmol. 116, 1740–1747 (2009)
11. A. Delong, Y. Boykov. Globally optimal segmentation of multi-region objects, in IEEE International Conference on Computer Vision (ICCV) (2009)
12. K. Li, X. Wu, D.Z. Chen, M. Sonka, Efficient optimal surface detection: theory, implementation and experimental validation. in Proceedings of SPIE International Symposium Medical
Imaging: Image Processing, vol. 5370 (May 2004), pp. 620–627
13. Y. Boykov, G. Funka-Lea, Graph cuts and efficient N-D image segmentation. Int. J. Comput.
Vis. (IJCV) 70, 109–131 (2006)
14. M. Niemeijer, K. Lee, X. Chen, L. Zhang, M. Sonka, M.D Abràmoff, Automated estimation of
fluid volume in 3D OCT scans of patients with CNV due to AMD, in ARVO Annual Meeting
(2012)
15. Y. Boykov, V. Kolmogorov, An experimental comparison of min-cut/max-flow algorithms for
energy minimization in vision. IEEE Trans. Pattern Anal. Mach. Intell. 26, 1124–1137 (2004)
16. X. Chen, M. Niemeijer, L. Zhang, K. Lee, M.D. Abràmoff, M. Sonka, 3D segmentation of fluidassociated abnormalities in retinal OCT: probability constrained graph-search–graph-cut. IEEE
Trans. Med. Imaging 31(8), 1521–1531 (2012)
17. Y. Boykov, M.P. Jolly, Interactive graph cuts for optimal boundary and region segmentation of
objects in ND images, in IEEE International Conference on Computer Vision (ICCV), vol. I
(2001), pp. 105–112
18. V. Kolmogorov, R. Zabih, What energy function can be minimized via graph cuts? IEEE Trans.
Pattern Anal. Mach. Intell. 26, 147–159 (2004)
19. O. Veksler, Star shape prior for graph-cut image segmentation, in 10th European Conference
on Computer Vision (ECCV), vol. 5304 (2008), pp. 454–467